TY  - GEN
AU  - Fujita,Tetsuo
AU  - Teh,Bin S
AU  - Timme,Terry L
AU  - Mai,Wei-Yuan
AU  - Satoh,Takefumi
AU  - Kusaka,Nobuyuki
AU  - Naruishi,Koji
AU  - Fattah,Elmoataz Abdel
AU  - Aguilar-Cordova,Estuardo
AU  - Butler,E Brian
AU  - Thompson,Timothy C
TI  - Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients
SN  - 0360-3016
PY  - 2006///0522
KW  - Acyclovir
KW  - analogs & derivatives
KW  - Adenoviridae
KW  - genetics
KW  - Aged
KW  - Aged, 80 and over
KW  - Androgen Antagonists
KW  - therapeutic use
KW  - Antiviral Agents
KW  - CD4-Positive T-Lymphocytes
KW  - immunology
KW  - CD8-Positive T-Lymphocytes
KW  - Combined Modality Therapy
KW  - methods
KW  - Genetic Therapy
KW  - Humans
KW  - Immunity, Cellular
KW  - Killer Cells, Natural
KW  - Male
KW  - Middle Aged
KW  - Prostatic Neoplasms
KW  - Radiotherapy, Intensity-Modulated
KW  - Thymidine Kinase
KW  - administration & dosage
KW  - Valacyclovir
KW  - Valine
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ijrobp.2005.11.009
ER  -